About This Report
This new 280-page report from Venture Planning Group presents detailed analysis of the Japanese STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes I/II, VI, Papillomavirus Pap Smear, HPV, and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.
In addition to market share and sales forecasts, the report:
- Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
- Reviews features and operating characteristics of major analyzers used
for STD testing;
- Profiles key suppliers and potential market entrants developing innovative
technologies and products; and
- Analyzes emerging opportunities, alternative market penetration strategies,
market entry barriers/risks, and strategic planning issues.
MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.
In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Groups proprietary data files was conducted.
Contains 280 pages and 17 tables
SIMILAR MARKET STUDIES
2016 Greece Hematology and Flow Cytometry Markets: Specimen, Sales and Volume Forecasts for 40 Tests, Competitive Strategies, Instrumentation Review, Technological Advances, Opportunities for Suppliers
Summary This new comprehensive report from VPGMarketResearch.com contains 225 pages and 5 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years. The report explores business and technological trends; provides specimen, sales and volume forecasts for 40 tests; compares ...
January 2016 | $0 | View Details >>
ICD Research's "Core-Mark Holding Company, Inc.: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, financial ratios, details of locations and subsidiaries, plus information on key news events affecting the company.
November 2011 | $99 | View Details >>
Complete report $11,800. DataPack (test volumes, sales forecasts, supplier shares) $7,700. The report is available by country, section, market segment, individual test, and can be custom-tailored to your specific information needs and budget. This new five-country study from VPGMarketResearch contains 700 pages, 54 tables, and is designed to help current suppliers ...
November 2015 | $7700 | View Details >>
Notes: Sales, means the sales volume of Central Nervous System (CNS) Biomarkers Revenue, means the sales value of Central Nervous System (CNS) Biomarkers This report studies sales (consumption) of Central Nervous System (CNS) Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these ...
October 2016 | $3900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research